In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is a devastating disease affecting about 1 out of 5000 male births and caused by mutations in the dystrophin gene. Genome editing has the potential to restore expression of a modified dystrophin gene from the native locus to modulate disease progression. In this stu...
Main Authors: | Nelson, C. E., Hakim, C. H., Ousterout, D. G., Thakore, P. I., Moreb, E. A., Rivera, R. M. C., Madhavan, S., Pan, X., Ran, F. A., Yan, W. X., Asokan, A., Duan, D., Gersbach, C. A., Zhang, Feng |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering |
Format: | Article |
Published: |
American Association for the Advancement of Science (AAAS)
2017
|
Online Access: | http://hdl.handle.net/1721.1/112732 https://orcid.org/0000-0003-2782-2509 |
Similar Items
-
In Vivo Gene Editing of Muscle Stem Cells with Adeno-Associated Viral Vectors in a Mouse Model of Duchenne Muscular Dystrophy
by: Jennifer B. Kwon, et al.
Published: (2020-12-01) -
Molecular genetics of Duchenne muscular dystrophy.
by: Kunkel, L, et al.
Published: (1986) -
Molecular studies of progressive muscular dystrophy (Duchenne).
by: Kunkel, L, et al.
Published: (1987) -
Conservation of the Duchenne muscular dystrophy gene in mice and humans.
by: Hoffman, E, et al.
Published: (1987) -
Single-swap editing for the correction of common Duchenne muscular dystrophy mutations
by: Andreas C. Chai, et al.
Published: (2023-06-01)